Federally funded WA biomedical start-ups
By Richard Schoonraad | Antibiotic diagnostics, Bacteria, Kidneys, News & Events, Targeted Drug DeliveryCutting-edge biopolymer 3D printed heart valve technology and a rapid and accurate test to identify the most effective antibiotic treatment have commenced commercialisation in Western Australia to help millions globally.…
Muscular dystrophy discovery increases likelihood more families will be diagnosed with muscle weakening diseases
By Richard Schoonraad | Genetic Disease, Genetic Disease, Genetics, Genome Biology and Genetic Diseases, Muscular Dystrophy, Neurological Disorders, News & EventsDiscovery changes the way geneticists analyse debilitating muscle diseases When several people in an extended family suffer from similar muscle weakening symptoms, the cause is typically a genetic disease such…
Gout medication gets FDA approval to treat heart disease on back of Perth led clinical trial
By Richard Schoonraad | News & EventsLow dose colchicine gets FDA Approval for secondary prevention of heart disease on the back of Perth led clinical trial Colchicine, a widely available gout medication, has received FDA approval…
Researchers find link to anti-ageing element
By Richard Schoonraad | Cancer, News & Events, Research, xOncofetal EcosystemResearchers discover that increasing a naturally occurring chemical slows ageing process Ageing is inevitable as systemic changes occur in our bodies, but the question that puzzled researchers at the Harry…
WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…
3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…
Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…
Science experiments go bush
By Richard Schoonraad | BioDiscovery, Community, Media Releases, News & EventsJigalong Remote Community School students, living on the edge of the Great Sandy Desert on the western side of the Rabbit Proof Fence, were last week introduced to the world…